Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Parenthetical)

v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Condensed Consolidated Statements of Operations and Comprehensive Loss    
Net Loss $ (4,273) $ (2,537)
Loss on foreign currency translation (181) 0
Total comprehensive loss (4,454) (2,537)
Comprehensive loss attributable to non-controlling interest 0 (1)
Comprehensive loss attributable to Synthetic Biologics, Inc. and Subsidiaries $ (4,454) $ (2,536)